MARKET

MMSI

MMSI

Merit Med
NASDAQ

Real-time Quotes | Nasdaq Last Sale

72.90
+0.64
+0.89%
Opening 14:29 09/27 EDT
OPEN
72.31
PREV CLOSE
72.26
HIGH
72.94
LOW
71.26
VOLUME
67.77K
TURNOVER
--
52 WEEK HIGH
73.85
52 WEEK LOW
41.57
MARKET CAP
4.10B
P/E (TTM)
145.63
1D
5D
1M
3M
1Y
5Y
3 Promising MedTech Stocks to Snap Up in Second-Half 2021
Backed by robust long-term prospects, investors can add three lucrative MedTech stocks, MMSI, ITGR and OFIX, to their watchlist.
Zacks · 4d ago
NextGen's (NXGN) New Partnership to Boost Patient Experience
Zacks.com · 5d ago
Veeva Systems' (VEEV) Cloud Applications Get Adopted by Emmes
Zacks.com · 6d ago
Sidoti: Fall Virtual Small Cap Investor Conference
Presentation Times and Weblinks Released for Over 130 Presenting CompaniesWednesday and Thursday, September 22 - 23, 2021NEW YORK, NY / ACCESSWIRE / September 21, 2021 / Sidoti & Company, LLC proudly releases the presentation schedule, with weblink click-t...
ACCESSWIRE · 6d ago
Here's Why You Should Hold on to Glaukos (GKOS) Stock Now
Zacks.com · 09/20 14:19
Fresenius Medical's (FMS) Deal to Boost Home Dialysis in Japan
Zacks.com · 09/20 14:16
BRIEF-Merit Medical Systems Inc Announces Positive Results In First-In-Human Study Of WRAPSODY Cell-Impermeable Endoprosthesis
reuters.com · 09/20 13:29
Merit Medical Announces Results Of First-In-Human Study Of WRAPSODY Cell-Impermeable Endoprosthesis
Prospective, observational study published in CardioVascular and Interventional Radiology1 reports 100% target lesion primary patency ("TLPP") rate without reintervention through 30 days, with a
Benzinga · 09/20 13:26
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MMSI. Analyze the recent business situations of Merit Med through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MMSI stock price target is 76.22 with a high estimate of 88.00 and a low estimate of 63.00.
EPS
Institutional Holdings
Institutions: 373
Institutional Holdings: 70.90M
% Owned: 126.00%
Shares Outstanding: 56.27M
TypeInstitutionsShares
Increased
81
1.81M
New
30
714.18K
Decreased
81
3.03M
Sold Out
22
136.85K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.66%
Healthcare Equipment & Supplies
-2.00%
Key Executives
Chairman/Director/President/Chief Executive Officer
Fred Lampropoulos
Chief Financial Officer/Treasurer
Raul Parra
Corporate Executive
Justin Lampropoulos
Corporate Executive
Joseph Wright
Chief Operating Officer
Ronald Frost
Chief Human Resource Officer
Michel Voigt
Other
Robert Fredericks
Secretary
Brian Lloyd
Director
Stephen Evans
Independent Director
A. Scott Anderson
Independent Director
Jill Anderson
Independent Director
Lonny Carpenter
Independent Director
David Floyd
Independent Director
Thomas Gunderson
Independent Director
James Hogan
Independent Director
F. Ann Millner
Independent Director
Lynne Ward
No Data
  • All
  • Financials
  • Insiders
More
About MMSI
Merit Medical Systems, Inc. is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices. Its endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products focused in four product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, and endoscopy.

Webull offers kinds of Merit Medical Systems, Inc. stock information, including NASDAQ:MMSI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MMSI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MMSI stock methods without spending real money on the virtual paper trading platform.